Literature DB >> 4669450

On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake.

E Slatopolsky, S Caglar, L Gradowska, J Canterbury, E Reiss, N S Bricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4669450     DOI： 10.1038/ki.1972.84

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  40 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease.

Authors:  K A Hruska; R Kopelman; W E Rutherford; S Klahr; E Slatopolsky; A Greenwalt; T Bascom; J Markham
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

Review 3.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

4.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

Review 5.  Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.

Authors:  Chang Hyun Byon; Yabing Chen
Journal:  Curr Osteoporos Rep       Date:  2015-08       Impact factor: 5.096

6.  On the adaptation in sodium excretion in chronic uremia. The effects of "proportional reduction" of sodium intake.

Authors:  R W Schmidt; J J Bourgoignie; N S Bricker
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

Authors:  S Lopez-Hilker; T Galceran; Y L Chan; N Rapp; K J Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

Review 8.  The kidney and bone metabolism: Nephrologists' point of view.

Authors:  Masafumi Fukagawa; Yasuhiro Hamada; Shohei Nakanishi; Motoko Tanaka
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

9.  Reversal of secondary hyperparathyroidism by cimetidine in chronically uremic dogs.

Authors:  A I Jacob; J M Canterbury; G Gavellas; P W Lambert; J J Bourgoignie
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

10.  Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro.

Authors:  E Slatopolsky; J Finch; M Denda; C Ritter; M Zhong; A Dusso; P N MacDonald; A J Brown
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.